Hannes H.

Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California.

Peptilogics, Inc. operates as an early-stage biotechnology company, that develops a new class of antibiotics with a novel mechanism of action derived from their eCAP (engineered cationic antibiotic peptide) platform for the treatment of multidrug-resistant infections. Its platform has the potential to produce antibiotics with broad-spectrum activity with low risk of generating resistance, due to the unique mechanism of action involving the targeted disruption of bacterial membranes. The company was founded by Jonathan Steckbeck and is headquartered in Pittsburgh, PA.

Beijing Immunochina Pharmaceuticals Co., Ltd. engages in the development of CAR-T technology and CAR-T cell products. The company was founded on April 14, 2015 by He Ting, Lu Xian, and Qi Fei Fei and is headquartered in Beijing, China.

GWC Inc (GWC) is a venture capital firm founded in 2008 by Wen Chu and Yiqun Bo. The firm is headquartered in Santa Clara, California.

Blackrock Microsystems, Inc. is a platform company that specializes in brain-computer interface (BCI) technology and the development of implantable solutions that improve human lives. The company is based in Salt Lake City, UT and has subsidiaries in the United States. Blackrock's precision electrode technology is at the core of many worldwide innovations in BCI, enabling dozens of early users to regain their ability to see, hear, move, and talk. Blackrock Microsystem's mission is to provide innovative tools and neurotech expertise to translate technology into novel, implantable clinical solutions that improve human lives. The company was founded in 2008 by Marcus Gerhardt and Florian Solzbacher, with Marcus Gerhardt serving as the CEO since then.